Global Specialty Generics Market by Type (Injectables and Oral Drugs), By Application (Oncology, Inflammatory Conditions, and Other Applications), By Distribution Channel (Specialty Pharmacy, Retail Pharmacy, and Other Distribution Channels) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 100792
- Number of Pages: 311
- Format:
-
keyboard_arrow_up
-
-
- Teva Pharmaceuticals Industries Ltd.
- Viatris Inc.
- Novartis AG Company Profile
- Hikma Pharmaceuticals PLC
- Mallinckrodt; Akorn, Inc.
- Bausch Health Companies Inc.
- Reddy's Laboratories Ltd.
- Endo Pharmaceuticals Inc.
- Apotex Corp.
- Sun Pharmaceutical Industries Ltd.
- Fresenius Kabi Brasil Ltd.
- Stada Arzeimittel AG
- Pfizer, Inc.
- Other Market Players
- settingsSettings
Our Clients
- 100792
- Oct 2023
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
